MENU
+Compare
NUVL
Stock ticker: NASDAQ
AS OF
Oct 6, 04:59 PM (EDT)
Price
$83.85
Change
-$0.37 (-0.44%)
Capitalization
6.05B

NUVL Nuvalent Forecast, Technical & Fundamental Analysis

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer... Show more

NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NUVL with price predictions
Oct 03, 2025

NUVL in upward trend: 10-day moving average moved above 50-day moving average on September 11, 2025

The 10-day moving average for NUVL crossed bullishly above the 50-day moving average on September 11, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 26, 2025. You may want to consider a long position or call options on NUVL as a result. In of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NUVL just turned positive on September 26, 2025. Looking at past instances where NUVL's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

NUVL moved above its 50-day moving average on September 26, 2025 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for NUVL moved above the 200-day moving average on September 04, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NUVL advanced for three days, in of 254 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 195 cases where NUVL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 49 cases where NUVL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NUVL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NUVL broke above its upper Bollinger Band on September 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.435) is normal, around the industry mean (23.241). P/E Ratio (0.000) is within average values for comparable stocks, (54.537). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.239). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (354.169).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NUVL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NUVL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NUVL is expected to report earnings to fall 2.16% to -136 cents per share on November 06

Nuvalent NUVL Stock Earnings Reports
Q3'25
Est.
$-1.36
Q2'25
Missed
by $0.17
Q1'25
Missed
by $0.05
Q4'24
Beat
by $0.03
Q3'24
Missed
by $0.34
The last earnings report on August 07 showed earnings per share of -138 cents, missing the estimate of -122 cents. With 462.18K shares outstanding, the current market capitalization sits at 6.05B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Broadway
Phone
+1 857 357-7000
Employees
92
Web
https://www.nuvalent.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMFAX61.990.10
+0.16%
American Funds American Mutual R1
FMGGX51.20N/A
N/A
Franklin Small-Mid Cap Growth R6
RISAX28.69N/A
N/A
Manning & Napier Rainier Intl Discv S
COMZX31.29N/A
N/A
DWS Digital Horizons Inst
DVFYX79.54-0.08
-0.10%
Davis Financial Y

NUVL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with XENE. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
+0.43%
XENE - NUVL
62%
Loosely correlated
+1.05%
CGON - NUVL
59%
Loosely correlated
-0.09%
RVMD - NUVL
59%
Loosely correlated
+2.21%
IDYA - NUVL
57%
Loosely correlated
+1.62%
NRIX - NUVL
57%
Loosely correlated
+3.30%
More